GridAI Technologies (GRDX) Interest Coverage Ratio (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Interest Coverage Ratio came in at 31.39 in Q4 2025, up 85.14% YoY from 16.95 in Q4 2024, and down 7439.78% on a QoQ basis from 0.42 in Q3 2025.
GridAI Technologies (GRDX) Interest Coverage Ratio (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Interest Coverage Ratio data on file, last reported at 31.39 in Q4 2025.
- Quarterly Interest Coverage Ratio rose 85.14% year-over-year to 31.39 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 47.42 (up 92.82% YoY) and the FY2025 annual result came in at 3.08, down 642.63% from the prior year.
- Interest Coverage Ratio fell to 31.39 in Q4 2025, from 0.42 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 12.92 in Q3 2022 to a low of 4662.62 in Q4 2021.
- A 5-year average of 323.8 and a median of 17.58 in 2021 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2021 — Interest Coverage Ratio slumped 135123.11% — and 2022, when it soared 122.42%.
- Tracing GRDX's Interest Coverage Ratio over 5 years: stood at 4662.62 in 2021, then jumped by 92.11% to 368.1 in 2022, then fell by 18.88% to 437.59 in 2023, then jumped by 51.72% to 211.25 in 2024, then jumped by 85.14% to 31.39 in 2025.
- The last three Interest Coverage Ratio figures came in at 31.39 (Q4 2025), 0.42 (Q3 2025), and 45.88 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.42 |
| 10 | GridAI Technologies | 5.97 Mn | 5.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.39 |
| Sep 30, 2025 | -0.42 |
| Mar 31, 2025 | -45.88 |
| Dec 31, 2024 | -211.25 |
| Sep 30, 2024 | -11.06 |
| Jun 30, 2024 | -40.65 |
| Mar 31, 2024 | -12.70 |
| Dec 31, 2023 | -437.59 |
| Sep 30, 2023 | -12.35 |
| Jun 30, 2023 | -15.04 |
| Mar 31, 2023 | -13.60 |
| Dec 31, 2022 | -368.10 |
| Sep 30, 2022 | 12.92 |
| Jun 30, 2022 | -15.00 |
| Mar 31, 2022 | -207.02 |
| Dec 31, 2021 | -4,662.62 |
| Sep 30, 2021 | -57.62 |
| Jun 30, 2021 | -17.58 |
| Mar 31, 2021 | -5.14 |
| Dec 31, 2020 | 3.45 |